| Endometrial Mixed Cell Adenocarcinoma studied in …STUDIED_INderived12 of 12show fewer |
|---|
| → studied in | NCT05256225Phase 3 · recruiting Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 12 trials mapped (6 active) | — | — | Endometrial Mixed Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05112601Phase 2 · recruiting Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma · condition mapped ONTOLOGY_EXACT · 12 trials mapped (6 active) | — | — | Endometrial Mixed Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03660826Phase 2 · active not recruiting Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone · condition mapped ONTOLOGY_EXACT · 12 trials mapped (6 active) | — | — | Endometrial Mixed Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03914612Phase 3 · active not recruiting Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (6 active) | — | — | Endometrial Mixed Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03120624Phase 1 · active not recruiting VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer · condition mapped CURATED_BROADER · 12 trials mapped (6 active) | — | — | Endometrial Mixed Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04719273Phase 2 · completed Onapristone and Anastrozole for the Treatment of Refractory Hormone Receptor Positive Endometrial Cancer · condition mapped CURATED_BROADER · 12 trials mapped (6 active) | — | — | Endometrial Mixed Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05542407Phase 1 · recruiting ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (6 active) | — | — | Endometrial Mixed Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01935934Phase 2 · completed Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (6 active) | — | — | Endometrial Mixed Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02020707Phase 1 · completed Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers · condition mapped ONTOLOGY_EXACT · 12 trials mapped (6 active) | — | — | Endometrial Mixed Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05390021NA · withdrawn PET/MRI in Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (6 active) | — | — | Endometrial Mixed Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02728258Phase 2 · completed Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (6 active) | — | — | Endometrial Mixed Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01935973Phase 1 · completed Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 12 trials mapped (6 active) | — | — | Endometrial Mixed Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |